NYSE · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · LARGE CAP
MSA Safety Inc. MSA
18 fiscal years on record · USD · FY2025 reported · SEC filings only
6 YEARS OF DIVIDEND GROWTH
Growth
USD 1.9B
Revenue, FY2025 · full 18-year series below
Revenue $B
Net income $B
FY2025 · Revenue 1.9 · Net income 0.3
Compound annual growth
+7.1%
+6.8%
+5.2%
+4.4%
+15.8%
+17.6%
+14.7%
+14.2%
+15.8%
+17.6%
+14.3%
+13.6%
+4.9%
+4.2%
+4.8%
+4.3%
+5.7%
+5.7%
3 yrs
5 yrs
10 yrs
15 yrs
Revenue compounded at +6.8% a year over five years — but profit grew faster: net income at +17.6%, earnings per share at +17.6%.
The share count fell from 0.04B to 0.04B over the period.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
15 cents
of every revenue dollar became profit
Operating margin
Net margin
FY2025 · Operating 19.8% · Net 14.9%
ROE
FY2022 · ROE 21.5%
The 18-year record
18 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 1.9 | 1.8 | 1.8 | 1.5 | 1.4 | 1.3 | 1.4 | 1.4 | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 1.1 |
| Operating income $B | 0.4 | 0.4 | 0.2 | 0.2 | 0.0 | 0.2 | 0.2 | 0.2 | 0.0 | 0.2 | 0.1 | 0.1 | · | · | · | · | · | · |
| EBITDA $B | 0.4 | 0.5 | 0.3 | 0.3 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | · | · | · | · | · | · |
| Income tax $B | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | 0.3 | 0.3 | 0.1 | 0.2 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 |
| Free cash flow $B | 0.3 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 |
| EPS, diluted $ | 7.09 | 7.21 | 1.48 | 4.56 | 0.54 | 3.15 | 3.52 | 3.18 | 0.67 | 2.42 | 1.87 | 2.33 | 2.34 | 2.42 | 1.87 | 1.05 | 1.21 | 1.96 |
| Dividend / sh $ | 2.10 | 2.00 | 1.87 | 1.82 | 1.75 | 1.71 | 1.64 | · | · | · | · | · | · | · | · | · | · | · |
| Payout % | 30 | 28 | 125 | 40 | 321 | 54 | 46 | 46 | 202 | 53 | 67 | 52 | 50 | 56 | 54 | 94 | 80 | 48 |
| ROE % | · | · | · | 21.5 | 2.6 | 15.9 | 20.3 | 20.2 | 4.5 | 17.1 | 13.5 | 16.1 | 17.1 | 20.2 | 15.8 | 8.6 | 9.9 | · |
| Shares out B | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 85 reconciliationsAUDITED
Reconciled in 18 of 19 fiscal years. 8 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityOrthopedic, Prosthetic & Surgical Appliances & Supplies
Listed onNYSE
Incorporated innot stated in the filings
Fiscal year endsDecember 31
Data on record since2008